Wolters Kluwer N.V. · EURONEXT:WKL
Wolters Kluwer — Q1 2007 Earnings Presentation
15 slides from Wolters Kluwer's earnings presentation, May 9, 2007
Slide 1: First-Quarter 2007 Results
First-Quarter 2007 Results May 9, 2007 - Amsterdam Nancy McKinstry CEO and Chairman of the Executive Board Boudewijn Beerkens CFO and Member of the Executive Board
Slide 2: Forward-Looking Statements
Forward-Looking Statements This presentation contains forward-looking statements. These statements may be identified by words such as "expect", "should", "could", "shall", and similar expressions. Wolters Kluwer cautions that such forward-looking statements are qualified by certain risks and uncerta
Slide 3: Agenda
Agenda Highlights Divisional Operating Performance Outlook Summary and Q&A Q1 2007 Results May 9, 2007 - Amsterdam 3
Slide 4: Highlights Q1 2007
Highlights Q1 2007 Q1 Key Financials — Revenue growth of 4% compared to Q1 2006 — Organic revenue growth of 3.3% — Ordinary EBITA margin of 19% against 15% in Q1 2006 — Structural cost savings of €37 million, an increase of 32% compared to last year — Strong free cash flow of €102 million compared
Slide 5: Agenda
Agenda Highlights Divisional Operating Performance Outlook Summary and Q&A Q1 2007 Results May 9, 2007 - Amsterdam 5
Slide 6: Health Results
Health Results Professional & Education Pharma Q1 07 showed overall flat organic revenue growth 40% Solutions Strong revenue growth at Ovid, core Pharma business and 32% on-line & software growth at Clinical Solutions (notably ProVation & Medispan) Offset by timing differences in wholesaler or
Slide 7: CFS Results
CFS Results Significant organic revenue growth of 8.5% in the quarter, driven largely by CLS Financial Services unit delivered solid Financial growth, both from banking and indirect Services lending, as well as securities and insurance 34% activities. Results were impacted by the continued slowd
Slide 8: TAL Results
TAL Results Organic growth of 1.1% for Q1 07 Overall revenues for the division increased 11% compared to same period last year, largely as a result of the Law & acquisitions at the SFS unit (ATX/Kleinrock and Taxwise) Business and good growth at the core NA Tax & Accounting business 34% Law &
Slide 9: LTRE Results
LTRE Results LTRE showed strong organic revenue growth of 4.9% SC in the first quarter, driven by strong on-line sales in BEL 4% FR Italy, Belgium, Spain and CEE and the timing of the 8% 19% Pharmagora trade show in France Good growth was achieved across the board through NL a combination of new
Slide 10: Agenda
Agenda Highlights Divisional Operating Performance Outlook Summary and Q&A Q1 2007 Results May 9, 2007 - Amsterdam 10
Slide 11: Divisional Outlook 2007 Reiterated
Divisional Outlook 2007 Reiterated Organic Revenue Growth Health 2-3% CFS 5-7% TAL 4-6% LTRE 2-4% Wolters Kluwer 4% Q1 2007 Results May 9, 2007 - Amsterdam 11
Slide 12: 2007 Outlook & Beyond Reiterated
2007 Outlook & Beyond Reiterated Key Operational Measures 20071 Beyond 20071 Organic revenue growth 4% 4-5% Continuous Ordinary EBITA margin 19-20% improvement Cash conversion 95-105% 95-105% Key Financial Measures Free cash flow ± €425 mln > €425 mln ROIC % ≥ WACC2 > WACC2 Ordinary diluted EPS €1.4
Slide 13: Agenda
Agenda Highlights Divisional Operating Performance Outlook Summary and Q&A Q1 2007 Results May 9, 2007 - Amsterdam 13
Slide 14: Summary
Summary Clear Clear strategic strategic focus focus based based on on four four strong strong businesses businesses Momentum Momentum for for stronger stronger organic organic revenue revenue growth growth continues continues Improved Improved margins margins from from cost cost savings savings and
Slide 15: First-Quarter 2007 Results
First-Quarter 2007 Results May 9, 2007 - Amsterdam Nancy McKinstry CEO and Chairman of the Executive Board Boudewijn Beerkens CFO and Member of the Executive Board